Organ and Tissue Transplantation Market Size, Share, Growth and Forecasts, 2016 to 2022

According to Stratistics MRC, the Global Organ and Tissue Transplantation market is estimated to be $XX billion in 2015 and is expected to reach $XX billion by 2022 growing at a CAGR of XX% from 2015-2022. Trend towards growing incidence of organ and tissue failure diseases is helping the market to compete across the globe. The market growth is fostered by some of the factors such as immensely enhanced immunosuppression regimens, advance tissue matching and improved harvesting and procurement techniques. However, shortage of organ donors and artificial organs will reflect the market strength. Moreover, huge investments in R&D will pose an opportunity for the organ and tissue transplantation market over the forecast period. By tissue transplantation, bone graft transplantation is a fastest growing segment during the forecast period.

Browse full report with TOC@ https://marketreportscenter.com/reports/415440/organ-and-tissue-transplantation-global-market-outlook-2016-2022

Some of the key players in this market include Johnson & Johnson, Medtronic Plc, Novartis AG, St. Jude Medical, Inc., World Heart Corporation, Edwards Lifescience, Lifeblood Medical, Inc, ABIOMED, Inc, Roche Pharmaceuticals and Stryker Corporation.

Organ Transplantation Covered:
Transplant Centers
Pancreas
Liver
Heart Lung
Kidney
Heart
Lungs
Intestine/Small Bowel

Tissue Transplantation Covered:
Cellular Transplantation
Blood Stem Cells
Skin Transplantation
Vascular Transplantation
Cornea
Bone Graft Transplantation

Application Covered:
Spinal Fusions
Carnio/Maxillofacial
General Orthopedics

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities,...